QUICK REFERENCE GUIDE FOR SCHOOL-BASED GRADE 9 IMMUNIZATIONS
Tdap Vaccine - Combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine
Manitoba Eligibility Criteria for Publicly Funded Vaccines: This vaccine is free of charge to students 14-16 years of age, individuals who missed the vaccine in grade 8 or 9 and are born on or after January 1, 1989, and all individuals ≥ 7 years of age who have not been previously immunized with pertussis vaccine. Trade Name/ Description Contents Supplied BOOSTRIX® Active Ingredients*: BOOSTRIX® GSK Diphtheria toxoid, tetanus toxoid, 3 purified pertussis antigens. is supplied as a turbid Combined diphtheria, tetanus, Inactive Ingredients: white suspension in a acellular pertussis (adsorbed) Adjuvant: aluminum (adsorbed onto aluminum salts) single dose vial or subunit vaccine for booster Other ingredients: sodium chloride and water for injection. prefilled syringe. Upon vaccination storage, a white deposit The product packaging is NOT declared latex free. and clear supernatant can be observed. ADACEL ® Active Ingredients*: ADACEL® is supplied Sanofi Pasteur Tetanus toxoid, diphtheria toxoid, 5 purified pertussis antigens as a sterile uniform, Tetanus toxoid, reduced Inactive Ingredients: cloudy, white suspension diphtheria toxoid, and acellular Aluminum Phosphate (adjuvant), 2-phenoxyethanol in a vial. pertussis vaccine (adsorbed). Manufacturing process residuals: Formaldehyde and glutaraldehyde are present in trace amounts. Shake the vial well until a Available for individuals that uniform, cloudy, have latex allergies. The vials are made of Type 1 glass. The container closure system suspension results. of ADACEL® is free of latex (natural rubber). Store refrigerated at 2°C to 8°C. Age Dose / Schedule Route / Needle Gauge /Length Ages four years and older. One 0.5 mL dose** IM (deltoid) 1 – 1 ½ ” 22-25 G Boosters for diphtheria and tetanus are recommended every 10 years. * The antigen content of this vaccine (including the pertussis content) is lower than in the vaccines used in preschool children. • ** There is no evidence of increased risk of severe adverse events for adolescents who receive diphtheria- and tetanus toxoid-containing vaccines at intervals of < 5 years. The pertussis booster (Tdap) should not be delayed for fear of adverse events related to the diphtheria or tetanus toxoid component, regardless of the elapsed time since the previous diphtheria and tetanus toxoid -containing vaccine. NACI Oct 2005 http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/acs-dcc-8-9/9-eng.php
Sources: Product Monographs GlaxoSmithKline (Boostrix)Feb. 1, 2013., Sanofi Pasteur ( Adacel) June 11,2012 & Canadian Immunization Guide Evergreen Ed. @ http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-dip-eng.php & http://www.sanofipasteur.ca/node/17902 & http://www.gsk.ca/english/html/our-products/vaccines-canada.html August 2013